VANCOUVER MYELOMA SUPPORT GROUP

Interactive, fun & educational meetings discussing
how to live with Myeloma & the latest treatments

LATEST NEWS FROM AMERICAN SOCIETY OF HEMATOLOGY 2022

    • Over 90% of patients respond to current therapies
    • Average first remission is 4 years or more
    • In 2021, average survival is at least 7 to 10 years
    • Some patients live over 15 to 20 years
    • New therapies are constantly improving the outlook

“Myeloma research is exploding.”    Dr. Donna Reese, Princess Margaret Hospital

“Your job is to stick around.”    H. Lalonde, 10 years living with myeloma                         

Scroll to Top